Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 3299586018 | Hepatitis C virus NS3/4A protease inhibitor (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 3299676012 | Hepatitis C virus NS3/4A protease inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module | 
| 3520744015 | Substance with hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 3520914010 | Substance with hepatitis C virus NS3/4A protease inhibitor mechanism of action | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 3745289010 | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module | 
| 3745291019 | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Is a | Substance with antiviral mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Has disposition | Hepatitis C virus NS3/4A protease inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Is a | Substance with protease inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Paritaprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Product containing Hepatitis C virus NS3/4A protease inhibitor (product) | Has active ingredient | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | 1 | 
| Boceprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Telaprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Simeprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Grazoprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Voxilaprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Glecaprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Grazoprevir | Is a | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Elbasvir + Grazoprevir | Has active ingredient | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Elbasvir 50mg / Grazoprevir 100mg tablets | Has active ingredient | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Zepatier 50mg/100mg tablets (Merck Sharp & Dohme (UK) Ltd) | Has active ingredient | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Glecaprevir | Is a | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Voxilaprevir | Is a | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Generic Vosevi 400mg/100mg/100mg tablets | Has active ingredient | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Vosevi 400mg/100mg/100mg tablets (Gilead Sciences Ltd) | Has active ingredient | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
| Zepatier 50mg/100mg tablets (Originalis B.V.) | Has active ingredient | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets